Sales for the largest 100 Chinese pharmaceutical firms increased 25.1% last year to $50.22 million to represent 42% of industry sales, according to the Southern Medicine Economic Research Institute, part of the State Food and Drug Administration. Total revenues for China’s pharmaceutical industry rose 20.8%. The top three drug companies were Harbin Pharmaceutical Group, Shijiazhuanh […]
Although estimated to be worth $10 billion by 2015, the biosimilars market will be challenging and thus is attracting only large companies and specialist providers. Development of biosimilars takes up to eight years at a cost of $100–$150 million. But prices are only expected to be 20%–30% lower than biologics. Multiple patent challenges are expected […]
At the request of the European Parliament, the European Commission’s Joint Research Center (JRC) has prepared a report assessing the challenges of creating a science-based definition of “nanomaterials” for regulatory purposes. The JRC recommends that the definition apply only to “particulate nanomaterials” and that size, not properties, be the defining property. For the definition, a […]
The Codex Alimentarius Commission, the United Nation’s food standards body, has announced new food standards. The maximum amount of melamine permitted in powdered infant formula was set at 1 mg/kg and at 2.5 mg/kg for other foods and animal feed. The Codex also set maximum levels for aflatoxins in ready-to-eat Brazil nuts at 10 µg/kg […]
As big oil projects become more complex and riskier, US and European oil companies are entering into deals for gas projects in Australia and America. In America, new shale-gas reserves have triggered a string of asset acquisitions. In contrast to oil, gas development costs have fallen and Western companies’ expertise and capital are in demand […]
The American Chemistry Council expects US chemical production to grow 6.0% this year, driven by the economic recovery and exports, and to rise 4.0% in 2011. Excluding pharmaceuticals, output is forecast to grow 6.8% in 2010. The fastest-growing sector this year will be bulk petrochemicals and organics, with output up 10.7%. Basic chemical production is […]
First-quarter revenues for the IBO Lab Equipment/Consumables Index jumped 12.0% to $4,162.38 million, including 3.7% growth from currency. Organic revenues grew 8.4% and benefited from declining inventories, improved pricing and higher demand, as well as a weak year-over-year comparison. Operating profits soared 25.7% to $746.18 million due to increased sales volumes and favorable currency transactions. […]
Quincy, IL 7/1/10—Gardner Denver, a provider of fluid transfer equipment, has acquired ILMVAC GmbH for an undisclosed amount. ILMVAC supplies vacuum pumps, systems and accessories for R&D labs and industrial applications. In 2009, ILMVAC had revenues of $11.6 million. “ILMVAC has technical expertise in applying existing vacuum technology for lab applications tailored, in particular, to […]
Tokyo, Japan 6/30/10—Hitachi High-Technologies has announced that Tokyo Customs has accepted its petition to deny the Japanese import of FEI’s Strata 400 scan ning/transmission electron microscope and Helios NanoLab 400S scanning electron microscope/focused ion beam (FIB) system. Hitachi High-Technologies charges that the systems violate its Japanese Patent Number 4100450. The company stated that it had […]
Darmstadt, Germany 7/15/10—Merck KGaA has announced the closing of its acquisition of Millipore for $7.0 billion (see IBO 3/15/10). The new company will be named Merck Millipore and will consist of three business units: Bioscience, Lab Solutions and Process Solutions. Headquartered in Billerica, Massachusetts, with 10,000 employees, Merck Millipore had 2009 pro forma revenues of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
